During ESMO 2023, oncologists came together to discuss lung cancer data emerging from the congress and the potential implications for clinical practice in the US, Japan and China. The meeting co-hosts each shared their views on key lung cancer data from three abstracts presented during ESMO before opening up the discussion to the panel. Watch the on-demand video to hear what they had to say.

 

Panel

  • Prof. Li Zhang, Sun Yat-sen University Cancer Center, Guangzhou, China

  • Prof. Tetsuya Mitsudomi, Kindai University, Osaka, Japan

  • Prof. Pasi A. Jänne, Dana-Farber Cancer Institute, Boston (MA), USA

  • Prof. Xiuning Le, MD Anderson Cancer Center, Houston (TX), USA

 

Clinical Takeaways

  • Updated results show that BL-B01D1 has potential in treating NSCLC patients who progressed after standard therapies.
  • In the KEYNOTE-671, perioperative pembrolizumab regimen significantly improves overall survival in resectable NSCLC versus placebo.
  • In the FLAURA2 trial, combining platinum-pemetrexed with osimertinib improves PFS in EGFR-mutated advanced NSCLC patients as compared to osimertinib alone, with a manageable safety profile.

 

Clinical Trials

  • BL-B01D1 bispecific EGFRxHER3 antibody drug conjugate trial
  • KEYNOTE-671
  • APG-1252 with Osimertinib for EGFR-mutant NSCLC
  • FLAURA2
  • RAMOSE
  • MARIPOSA

  • Inform oncologists about the latest clinical insights in lung oncology presented during EMSO 2023
  • Understand the impact of the latest clinical insights on clinical practice in the US, Japan and China

Programme summary
  • clock Duration 43 MIN
  • clock Language(s) flag
Watch the video now
Share this programme
This educational programme is supported by an Independent Medical Education Grant from SystImmune and BeiGene Europe.
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
LUNG CONNECT

Meet the experts

Other programmes of interest

Podcast
Oncology 
Colorectal cancer: understanding the needs of different patient populations

Exploring the impacts of age, ethnicity, socioeconomic status, and access to healthcare on patients with colorectal cancer

Experts
Prof. Tanios Bekaii-Saab, Deneen Richmond, Oncology Brothers (Moderators)
Endorsed by
COLONTOWN
  • download Downloadable
    Resources
  • clock 25 MIN
  • calendar May 2024

Educational programme supported by an Independent Medical Education grant from Bayer.
China Europe Anti-Cancer Summit_C2E2403 Other
Oncology 
2nd China-Europe Anti-Cancer Summit 2024: On-demand webinar

Oncologists review basic research and share the latest achievements in clinical practice

Experts
Prof. Yihai Cao, Prof. Ying Wang, Prof. Daiming Fan, Prof. Csaba L. Dégi
  • clock 101 MIN
  • calendar May 2024

This educational programme is supported by an Independent Medical Education Grant from BeiGene.
Podcast
Oncology 
Interpreting real-world evidence in later-line mCRC

Aligning real-world evidence with clinical trial data 

Experts
Prof. Tanios Bekaii-Saab, Prof. Shubham Pant
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar May 2024

Educational programme supported by an Independent Medical Education grant from Bayer.
Podcast

Episode

1

of 3

episode
Oncology 
Cáncer de próstata: Dificultades en la fase preanalítica y pruebas de biomarcadores (Spanish)

Moderado por los Oncology Brothers. Episodio 1 de una serie de podcast de video de 3 partes.

Experts
Dr Alexander Wyatt, Dr Petros Grivas, Oncology Brothers (Moderators)
Endorsed by
NASPCC AMP
  • download Downloadable
    Resources
  • clock 30 MIN
  • calendar May 2024

Educational programme supported by an Independent Medical Education grant from AstraZeneca and Amoy Diagnostics.
Podcast

Episode

3

of 3

episode
Oncology 
Câncer de Ovário: Desafios da fase pré-analítica e teste de biomarcadores (Portuguese)

Moderado pelos Oncology Brothers. Episódio 3 da série de podcasts em vídeo de 3 partes

Experts
Assoc. Prof. Martina Murphy, Assoc. Prof. Caterina Marchiò, Oncology Brothers (Moderators)
Endorsed by
AMP
  • download Downloadable
    Resources
  • clock 32 MIN
  • calendar May 2024

Educational programme supported by an Independent Medical Education grant from AstraZeneca and Amoy Diagnostics.
Podcast

Episode

3

of 3

episode
Oncology 
Cáncer de ovario: Dificultades en la fase preanalítica y pruebas de biomarcadores (Spanish)

Moderado por los Oncology Brothers. Episodio 3 de una serie de podcast de 3 partes.

Experts
Assoc. Prof. Martina Murphy, Assoc. Prof. Caterina Marchiò, Oncology Brothers (Moderators)
Endorsed by
AMP
  • download Downloadable
    Resources
  • clock 32 MIN
  • calendar May 2024

Educational programme supported by an Independent Medical Education grant from AstraZeneca and Amoy Diagnostics.